1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 23 MARCH 2015

Cancer Drug News 23 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Lilly Can Use Local Biotech To Grow Presence In China
Industry Brief - NKTR-102 Prolongs Median OS In Phase III BC Study
Industry Trend Analysis - Imbruvica Will Allow AbbVie To Recoup After Costly Pharmacyclics Deal
Industry Trend Analysis - EC Approval For PV Pushes Jakavi Closer To Blockbuster Status
Industry Brief - Vaxil's ImMucin Gains EU Orphan Drug Designation For MM
Industry Brief - BioInvent To Conduct Phase IIa Study In MM Post ASCT
Industry Brief - Coronado/NeuPharma To Co-Develop Covalent Third-Generation EGFr Inhibitors
Industry Brief - Tokai/QIAGEN Expand Deal To Develop AR-V7 Companion Diagnostic
Industry Brief - Lonsurf Combination Tablet Approved In Japan For Partial Change In Indications
Industry Brief - BioInvent To Initiate TB-403 Phase I/IIa Programme In Medulloblastoma
Industry Brief - Nova Secures Funds To Develop Liquid Formulation Of 13-CRA
Industry Brief - Opdivo Approved In South Korea For Melanoma
Industry Brief - Myriad And BioMarin Expand Companion Diagnostic Collaboration
Industry Brief - Celldex/Roche Enter Clinical Trial Collaboration For Varlilumab/MPDL3280A
Industry Brief - Vaccinex/Five Prime Sign Multi-Target Ab Discovery Deal
Industry Trend Analysis - Teva Deal Highlights Ignyta's Strong Future In Oncology Market
Industry Trend Analysis - Genmab Bolsters Pipeline With iDD Antibody Deal
Industry Trend Analysis - AstraZeneca Preparing Well To Stave Off Potential Further Takeover Bids
Industry Brief - Aeglea Raises Funds To Develop Treatments For Inborn Errors Of Metabolism
Industry Brief - Kite Strengthens TCR Product Platform With T-Cell Factory Acquisition

Table Of Contents

Cancer Drug News 23 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.